SRC proximal and core promoter elements dictate TAF1 dependence and transcriptional repression by histone deacetylase inhibitors

被引:22
作者
Dehm, SM
Hilton, TL
Wang, EH
Bonham, K
机构
[1] Saskatchewan Canc Agcy, Canc Res Unit, Hlth Res Div, Saskatoon, SK S7N 4H4, Canada
[2] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada
[3] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA
关键词
D O I
10.1128/MCB.24.6.2296-2307.2004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Histone deacetylase inhibitors (HDIs) induce cell cycle arrest, differentiation, or apoptosis in numerous cancer cell types both in vivo and in vitro. These dramatic effects are the result of a specific reprogramming of gene expression. However, the mechanism by which these agents activate the transcription of some genes, such as p21(WAF1), but repress others, such as cyclin D1, is currently unknown. We have been studying the human SRC gene as a model for HDI-mediated transcriptional repression. We found previously that both the tissue-specific and housekeeping SRC promoters were equally repressed by HDIs. Here we show that, despite an overt dissimilarity, both SRC promoters do share similar core promoter elements and transcription is TAF1 dependent. Detailed analysis of the SRC promoters suggested that both core and proximal promoter elements were responsible for HDI-mediated repression. This was confirmed in a series of promoter-swapping experiments with the HDI-inducible, TAFl-independent p21(WAF1) promoter. Remarkably, all the SRC-p21(WAF1) chimeric promoter constructs were not only repressed by HDIs but also dependent on TAF1. Together these experiments suggest that the overall promoter architecture, rather than discrete response elements, is responsible for HDI-mediated repression, and they implicate core promoter elements in particular as potential mediators of this response.
引用
收藏
页码:2296 / 2307
页数:12
相关论文
共 54 条
[1]   Butyrate inhibits colon carcinoma cell growth through two distinct pathways [J].
Archer, S ;
Meng, SF ;
Wu, J ;
Johnson, J ;
Tang, R ;
Hodin, R .
SURGERY, 1998, 124 (02) :248-253
[2]   p21WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells [J].
Archer, SY ;
Meng, SF ;
Shei, A ;
Hodin, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) :6791-6796
[3]  
Biscardi JS, 1999, ADV CANCER RES, V76, P61
[4]   An alternative, human SRC promoter and its regulation by hepatic nuclear factor-1α [J].
Bonham, K ;
Ritchie, SA ;
Dehm, SM ;
Snyder, K ;
Boyd, FM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (48) :37604-37611
[5]  
BONHAM K, 1993, ONCOGENE, V8, P1973
[6]   DNA binding site selection by RNA polymerase II TAFs:: a TAFII250-TAFII150 complex recognizes the Initiator [J].
Chalkley, GE ;
Verrijzer, CP .
EMBO JOURNAL, 1999, 18 (17) :4835-4845
[7]   Transcription activation: Unveiling the essential nature of TFIID [J].
Chen, BS ;
Hampsey, M .
CURRENT BIOLOGY, 2002, 12 (18) :R620-R622
[8]  
Chen JL, 1996, METHOD ENZYMOL, V273, P208
[9]   SRC transcriptional activation in a subset of human colon cancer cell lines [J].
Dehm, S ;
Senger, MA ;
Bonham, K .
FEBS LETTERS, 2001, 487 (03) :367-371
[10]   Requirement for TAFII250 acetyltransferase activity in cell cycle progression [J].
Dunphy, EL ;
Johnson, T ;
Auerbach, SS ;
Wang, EH .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (04) :1134-1139